Given the broad effects of OX40 on CD4 + T cell responses, it remains to be defined how OX40 intersects with cytokine signals in fine tuning the differentiation of various helper T cell subsets and the molecular pathways involved, and whether OX40 favors a specific subset or broadly affects all helper T cell subsets. Here we addressed those questions by assessing the induction of various CD4 + T cell subsets under TGF-β-based polarizing conditions. We found that OX40 was highly selective and potent in the induction of T H 9 cells and operated through activation of the noncanonical NF-κB pathway.
After the T cell antigen receptor is triggered, the fate of the T cells is controlled to a large extent by signals from T cell-costimulatory molecules and cytokines 1, 2 . For naive CD4 + T cells, the cytokine milieu in which the cells are activated directs CD4 + T cells to further differentiate into functionally different subsets (the T H 1, T H 2, T H 9 and T H 17 subsets of helper T cells, induced regulatory cells (iT reg cells) or follicular helper T cells) that in turn mediate different types of T cell immunity or immune system-related diseases 3 . For example, transforming growth factor-β (TGF-β) converts conventional CD4 + T cells into immunosuppressive iT reg cells by turning on expression of the transcription factor Foxp3, whereas TGF-β in combination with the inflammatory cytokines interleukin 1 (IL-1), IL-6 or tumor-necrosis factor (TNF) induces the transcription factors RORγt, RORα and c-Rel that program the induction of T H 17 cells 4 . Published studies have suggested that TGF-β, together with IL-4, promotes IL-9-producing T H 9 cells through induction of the transcription factors PU. 1 and IRF4 (refs. 5, 6) , although the exact nature of this response and the precise identity of T H 9 cells remain somewhat contested. Additionally, activation of CD4 + T cells in an IL-12-rich environment (without TGF-β) stimulates expression of the transcription factor T-bet, which programs the induction of T H 1 cells, whereas an IL-4-rich environment supports T H 2 cells via induction of the transcription factor GATA-3 (ref. 7) . This is of fundamental importance in immunology, as individual T cell subsets are often tailored to respond to specific pathogens. Thus, by inducing specific transcription factors, cytokines are critical in directing the differentiation of CD4 + T cell subsets.
OX40 (CD134) is a T cell-costimulatory molecule of the TNF receptor superfamily and traditionally signals through the transcription factor NF-κB pathway 8 . OX40 is rapidly induced after T cell activation, most prominently on activated CD4 + T cells, and costimulation via OX40 exerts a broad effect on the overall T cell immunity 9 . In physiological immune responses, OX40 delivers a potent costimulatory signal to activated CD4 + T cells, which supports their survival and proliferation 9 . OX40 also inhibits Foxp3 + T reg cells 10, 11 , which may indirectly boost effector T cells by relieving them of T reg cell-mediated suppression. Furthermore, OX40 directly drives either a T H 1 response or a T H 2 response in various models, which indicates a key role for OX40 in the control of the helper T cell differentiation process 12, 13 . OX40 is also involved in the development of CD4 + memory T cells, possibly by sustaining expression of the survival factor Bcl-2 (ref. 14) , and in some models it is indispensable in memory recall responses 15 . However, OX40 can also contribute substantially to immunopathology in a variety of animal models. For example, transgenic overexpression of the ligand for OX40 (OX40L) in C57BL/6 (B6) mice induces spontaneous and systemic autoimmune diseases characterized by enhanced production of autoantibodies, severe inflammation in the gut and extensive interstitial pneumonia 16 . Also, costimulation via OX40 has been linked to the pathogenesis of autoimmune colitis, experimental autoimmune encephalitis, arthritis, asthma and transplant rejection 17 . Such a diversity of responses suggests that OX40 probably uses a variety of mechanisms to control immunity or immunopathology.
IL-2 (10 ng/ml), and ~80% of CD4 + T conv cells became Foxp3 + cells 3 d later (Fig. 1a) . However, such induction of iT reg cells was substantially inhibited when we activated CD4 + T conv cells with anti-CD3 plus OX40L-transgenic APCs. We observed similar inhibition of iT reg cells by OX40 in an antigen-specific setting in which we activated OT-II cells (which have transgenic expression of a T cell antigen receptor specific for ovalbumin (OVA)) with cognate OVA peptide presented by either wild-type APCs or OX40L-transgenic APCs (Fig. 1a) . The conversion of CD4 + T conv cells into T H 17 cells by TGF-β plus IL-6 was also inhibited by ligation of OX40. TGF-β (3 ng/ml) and IL-6 (10 ng/ml) converted ~35% of the CD4 + T conv cells into IL-17-producing cells 3 d after activation of the T conv cells with anti-CD3 plus wild-type APCs, whereas CD4 + T conv cells activated without polarizing cytokines did not undergo T H 17 induction; however, ligation of OX40 prevented the induction of IL-17-producing cells under identical T H 17-polarizing conditions (Fig. 1b) . We did extensive 'titration' of cytokines used in the cultures (0.5-3 ng/ml for TGF-β and 10-30 ng/ml for IL-2 and IL-6) and found a consistent effect of OX40 on the suppression of iT reg cells and T H 17 cells (data not shown). Therefore, OX40 effectively shut down the reciprocal induction of both iT reg cells and T H 17 cells.
We further examined whether OX40 also affected the induction of T H 9 cells by TGF-β and IL-4 and found that OX40 had a diametrically opposite effect on this induction. TGF-β (3 ng/ml) plus IL-4 (10 ng/ml) converted ~7% of CD4 + T conv cells into T H 9 cells under the condition of stimulation with anti-CD3 plus wild-type APCs by 3 d after culture (Fig. 1c) ; this was within the published range of most studies 5, 6, 20 . Culturing CD4 + T conv cells with anti-CD3 plus OX40L-transgenic APCs considerably enhanced the induction of T H 9 cells; as many as 50% of the CD4 + T conv cells became IL-9 b a Ctrl WT 
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A r t i c l e s producing cells. Additionally, instead of using OX40L-transgenic APCs, we used anti-CD3 plus wild-type APCs to activate CD4 + T conv cells and included the OX86 agonist mAb to OX40 to engage OX40 signaling. OX86 also substantially enhanced the induction of T H 9 cells (Fig. 1d) . We established the specificity of OX40 in the induction of T H 9 cells by activating wild-type B6 and OX40-deficient CD4 + T conv cells under T H 9-polarizing conditions. We found that the T H 9 induction of OX40-deficient T cells remained similar (~5%) regardless of whether they were activated with anti-CD3 plus wild-type APCs or anti-CD3 plus OX40L-transgenic APCs, whereas wild-type CD4 + T cells were readily converted into T H 9 cells (~50%) by TGF-β plus IL-4 after activation with anti-CD3 plus OX40L-transgenic APCs (Fig. 1e) . Furthermore, the induction of T H 9 cells by OX40 was even greater in an antigen-specific setting in which we activated OT-II cells with the cognate OVA antigen under T H 9-polarizing conditions. We found that ~80% of the OT-II cells were converted into T H 9 cells by TGF-β plus IL-4 in the presence of ligation of OX40, whereas OT-II cells activated without polarizing cytokines showed no T H 9 conversion (Fig. 2a) , which contrasted with the conversion of OT-II cells polarized without ligation of OX40 (~9%). Notably, T H 9 cells induced under conditions of ligation of OX40 did not express other cytokines, as demonstrated by costaining for IL-4, IL-5, IL-10, IL-13, interferon-γ or IL-17 ( Fig. 2b) . In addition, quantitative real-time PCR and enzyme-linked immunosorbent assay (ELISA) showed considerable expression of IL-9 mRNA and IL-9 protein by CD4 + T conv cells polarized under T H 9 conditions in the presence of ligation of OX40 (Fig. 2c,d ).
We repeated the T H 9-induction experiments up to ten times with consistent results. We also 'titrated' the cytokines used in the cultures (0.5-3 ng/ml for TGF-β, and 10-30 ng/ml for IL-4) and varied the time points (3-5 d of culture) and found that OX40 consistently favored the T H 9 polarization of cells (data not shown). Together these experiments demonstrated the potency of OX40 costimulation in selective induction of T H 9 cells.
PU.1 is dispensable for T H 9 induction by OX40
Published studies of other experimental conditions have identified the transcription factor PU.1 (encoded by Sfp1) as a key transcription factor for the induction of T H 9 cells 6 . The potency of OX40 in the induction of T H 9 cells led us to investigate whether PU.1 was also involved in the OX40-mediated induction of T H 9 cells. For this, we bred mice with loxP-flanked Sfp1 alleles (Sfp1 f/f mice) with mice expressing Cre recombinase under control of the gene encoding CD4 (Cd4-Cre mice) for specific deletion of Sfp1 in CD4 + T cells in the offspring of this cross (Sfp1 f/f Cd4-Cre mice). We sorted CD4 + T conv cells from Sfp1 f/f Cd4-Cre mice by flow cytometry and stimulated them with anti-CD3 plus either wild-type B6 or OX40L-transgenic APCs under T H 9-polarizing conditions and examined the induction of IL-9-producing cells by flow cytometry. Wild-type and Sfp1 f/f Cd4-Cre CD4 + T cells had similar expression of OX40 on the cell surface after activation (Fig. 3a) , and both proliferation and survival were also similar in those two populations after activation with anti-CD3 plus wild-type APCs (Fig. 3b) . Thus, deletion of Sfp1 in CD4 + T cells did not alter OX40 expression or cellular activation. When we subjected wild-type and Sfp1 f/f Cd4-Cre CD4 + T conv cells to the same T H 9-polarizing conditions (with activation by anti-CD3 plus wild-type APCs), ~6% of the former and ~3% of the latter were converted into IL-9 producing cells; thus, ~50% fewer of the latter were converted (Fig. 3c) , consistent with a role for PU.1 in the induction of T H 9 cells under certain conditions 6 . When OX40 was engaged in the cultures (with activation by anti-CD3 plus OX40L-transgenic APCs), the induction of T H 9 cells by TGF-β plus IL-4 was essentially the same for wild-type and Sfp1 f/f Cd4-Cre CD4 + T conv cells, and in either case, ~40% of the CD4 + T conv cells were converted into IL-9-producing cells (Fig. 3c) . We obtained similar results with cultures in which we activated wild-type and Sfp1 f/f Cd4-Cre CD4 + T cells with anti-CD3 plus wild-type APCs and added mAb OX86 to stimulate OX40 signaling (data not shown). These findings suggested that PU.1 was dispensable in the OX40-mediated induction of T H 9 cells. 
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Wild-type CD4 + T conv cells showed no alteration in TGF-β signaling after activation with or without ligation of OX40, as assessed by immunoblot analysis of the expression of the signal-transducer Smad proteins and phosphorylation of Smad2, Smad 3 and Smad7 (Fig. 3d) ; these results were compatible with a need for TGF-β in the induction of T H 9 cells by OX40. Furthermore, expression of the interleukin receptors IL-2Rα, IL-4Rα and IL-6Rα, as well as phosphorylation of the transcription factors STAT5, STAT6 and STAT3, were identical in CD4 + T conv cells activated in the presence or absence of ligation of OX40 (Fig. 3e) . Thus, OX40 seemed to use a previously unknown mechanism that specifically favored the induction of T H 9 cells.
OX40 activates canonical and noncanonical NF-kB pathways
As a member of the TNF receptor superfamily, OX40 signals mainly through the activation of NF-κB, which consists of both a canonical pathway (p50-RelA) and a noncanonical pathway (p52-RelB) 21 . We did a series of experiments to simultaneously assess expression of the components of those pathways during T cell activation. We activated wild-type B6 CD4 + T conv cells in vitro for various times with or without ligation of OX40, followed by extraction of both cytosolic and nucleus proteins from the activated cells. We assessed the induction of key molecules involved in the activation of each NF-κB pathway by immunoblot analysis. At 36 h after T cell activation, there was considerable induction of the generation of p105 (the precursor of p50) in the cytosol; the generation of p50 was similarly induced in CD4 + T conv cells activated with or without ligation of OX40 (Fig. 4a) . There was also considerable induction of the generation of p100 (the precursor of p52) in the cytosol, but p100 was processed to generate p52 only under conditions of ligation of OX40 (Fig. 4a) . Accumulation of p50 and RelA in the nucleus (the canonical pathway) was prominent in CD4 + T conv cells activated with either anti-CD3 plus wild-type APCs or anti-CD3 plus OX40L-transgenic APCs. In contrast, we observed accumulation of p52 and RelB in the nucleus (the noncanonical pathway) only in CD4 + T conv cells activated in the presence of ligation of OX40 (Fig. 4b) . These data suggested that the canonical NF-κB pathway (p50-RelA) was the default pathway in activated T cells and that ligation of OX40 additionally activated the noncanonical pathway (p52-RelB) in CD4 + T cells.
Kinetic analyses showed considerable differences in the timing of the activation of the canonical and noncanonical NF-κB pathways by OX40. The induction of the generation of p105 and p50 in the cytosol by OX40, as well as the translocation of RelA and p50 to the nucleus, were rapid and transient and occurred mainly in the first 24 h and 48 h after T cell activation (Fig. 4c,d) . In contrast, the induction of the generation of p52 and RelB by OX40 and the accumulation of p52 and RelB in the nucleus were slow but sustained, and 3 d after T cell activation, when p50 and RelA were barely detectable in the nucleus, nuclear expression of p52 and RelB remained very high in T cells in which OX40 was ligated (Fig. 4d) . These data suggested that OX40 triggered the activation of both NF-κB pathways; although activation of the canonical pathway was transient, activation of the noncanonical NF-κB pathway was sustained for a much longer period of time.
OX40 requires the noncanonical pathway in T H 9 induction
To delineate the roles of the canonical versus noncanonical NF-κB pathways in the induction of T H 9 cells by OX40, we used both lossof-function and gain-of-function approaches. We bred mice with transgenic overexpression (driven by the promoter of the gene encoding the kinase Lck) of a dominant negative mutant form of the NF-κB inhibitor IκBα (IκBα∆N) that is resistant to phosphorylation and degradation; therefore, in these IκBα∆N-transgenic mice, the canonical NF-κB pathway is constitutively repressed 22 . We crossed 
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IκBα∆N-transgenic mice with Foxp3-GFP reporter mice and sorted naive CD4 + T conv cells from the offspring by flow cytometry. We stimulated the sorted CD4 + T conv cells with anti-CD3 plus wild-type or OX40L-transgenic APCs under T H 9-polarizing conditions and assessed the induction of IL-9-producing cells by flow cytometry. We confirmed that in the sorted IκBα∆N-transgenic CD4 + T cells, activation of the canonical pathway (p50-RelA) was substantially inhibited but induction of the noncanonical pathway (p52-RelB) by ligation of OX40, as well translocation of p52-RelB to the nucleus, were similar to that in wild-type CD4 + T cells (Fig. 5a,b) . We also confirmed that IκBα∆N-transgenic T cells had expression of OX40 similar to that of wild-type T cells after activation in vitro; they also proliferated vigorously after stimulation with anti-CD3 plus wild-type APCs and were not apoptotic (Supplementary Fig. 1 ). The induction of T H 9 cells by OX40 was similar for wild-type B6 and IκBα∆N-transgenic CD4 + T cells, and in either case, ~40% of CD4 + T conv cells were converted into IL-9 producing cells 3 d after culture (Fig. 5c) .
In another set of experiments, we stimulated wild-type B6 CD4 + T conv cells with anti-CD3 plus OX40L-transgenic APCs under T H 9-polarizing conditions, and in these cultures, we added a chemical inhibitor of the activation of the canonical NF-κB pathway (BAY 11-7082) that selectively inhibits phosphorylation of IκBα 23 , then assessed the induction of T H 9 cells at various time points. The doses of BAY 11-7082 used potently inhibited the activation of IκBα (Fig. 5d) . We observed that the induction of T H 9 cells by OX40 was not affected by the addition of BAY 11-7082 despite substantial inhibition of IκBα, and ~40% of the CD4 + T conv cells became T H 9 cells regardless the presence or absence of BAY 11-7082 (Fig. 5e) . Thus, the canonical NF-κB pathway seemed to be dispensable in the OX40-mediated induction of T H 9 cells.
To determine whether the noncanonical pathway has any role in the induction of T H 9 cells, we bred p52-deficient mice in which activation of the noncanonical pathway (p52-RelB) is prevented because of the lack of p52 generation 24, 25 . We sorted CD4 + T conv cells from p52-deficient mice, activated them under T H 9-polarizing conditions with or without ligation of OX40 and assessed the induction of T H 9 cells 3 d later. First, we demonstrated that wild-type B6 and p52-deficient CD4 + T cells were similar in OX40 expression, proliferation (as shown by dilution of the cytosolic dye CFSE) and survival (as shown by staining with annexin V) after activation with anti-CD3 plus APCs in vitro (Supplementary Fig. 2 ). Approximately 40% of 
wild-type CD4 + T conv cells were converted into IL-9-producing cells by TGF-β plus IL-4 after activation with anti-CD3 and OX40L-transgenic APCs (Fig. 6a) . However, p52-deficient CD4 + T conv cells were not converted into T H 9 cells under identical culture conditions (Fig. 6a) . Thus, the noncanonical p52-RelB pathway had a key role in the OX40-mediated induction of T H 9 cells.
We then used a gain-of-function approach to ascertain the role of the p52-RelB pathway in the induction of T H 9 cells. We used retrovirus-mediated gene transfer to overexpress p52-RelB in wildtype CD4 + T cells and then assessed the induction of T H 9 cells by TGF-β plus IL-4 only (without ligation of OX40). When we cultured successfully transduced wild-type CD4 + T conv cells (marked by GFP expression) under T H 9-polarizing conditions, as many as 50% of these cells became IL-9-producing cells, whereas cells transduced with control vector had minimal IL-9 expression (<5%) under identical culture conditions (Fig. 6b) . In contrast, wild-type CD4 + T cells transduced to overexpress p50-RelA did not show substantial induction of IL-9 under the same polarizing conditions (Fig. 6c) , which established the specificity of the p52-RelB pathway in the induction of T H 9 cells by OX40. These findings complemented the data obtained with p52-deficient CD4 + T cells and together they demonstrated a role for the p52-RelB pathway in the induction of T H 9 cells by OX40.
Sequence analysis of the promoter region of Il9 identified two putative NF-κB-binding sites (Fig. 6d) , and chromatinimmunoprecipitation (ChIP) analysis showed that p52-RelB directly bound to and showed 'preferential' enrichment at the promoter region of Il9 in T H 9 cells polarized under conditions of ligation of OX40 (Fig. 6e) . However, ChIP analysis of p50-RelA in similarly polarized T H 9 cells did not show selective enrichment of p50-RelA in the promoter region of Il9 (Fig. 6f) . These data suggested that p52-RelB may have the potential to directly drive transcription of Il9. To test this possibility, we cloned ~1,000 base pairs of the promoter region of Il9 upstream of the start site into a luciferase reporter gene and transfected this construct into human embryonic kidney 293T cells. We then assessed luciferase activity with or without cotransfection of expression constructs for p52-RelB and found significantly more Il9 promoter activity in the presence of p52-RelB (Fig. 6g) .
TRAF6 is critical to the induction of the p52-RelB pathway
The requirement for p52-RelB in the induction of T H 9 cells prompted us to examine how OX40 triggered activation of the noncanonical NF-κB pathway. A key step in the activation of NF-κB by members of the TNF receptor superfamily is the recruitment of TRAF proteins, the adaptors required for downstream signaling 26 . RT-PCR-based array analysis of all known TRAF proteins in activated CD4 + T conv cells (48 h after activation) showed that TRAF6 mRNA was 'preferentially' induced after ligation of OX40, whereas the expression of mRNA for other TRAF proteins was not much different with or without ligation of OX40 (Fig. 7a) . We further confirmed by immunoblot analysis the higher expression of TRAF6 protein in CD4 + T conv cells after stimulation with OX40, and the difference in TRAF6 expression by activated CD4 + T cells with or without ligation of OX40 was notable (Fig. 7b) .
In addition to acting as an adaptor, TRAF6 also functions as an ubiquitin ligase 27 . The exact role of TRAF6 in regulating OX40 signaling in T cells has not been examined, to our knowledge. We crossed mice with loxP-flanked Traf6 alleles (Traf6 f/f mice) with Cd4-Cre mice for specific deletion of Traf6 in CD4 + T cells in the Traf6 f/f Cd4-Cre offspring 28 . We sorted CD4 + T conv cells from wild-type B6 and Traf6 f/f Cd4-Cre mice, activated them with anti-CD3 plus wild-type (Fig. 7c) , which confirmed a published report of a different model of this 29 . Activation of NIK mediated the processing of p100 to p52, and this further correlated very well with prominent accumulation of p52 and RelB in the nucleus (Fig. 7c,d) . Deletion of Traf6 in CD4 + T conv cells prevented the induction of NIK by OX40 and the subsequent generation of p52 from p100. The defective generation of p52 in Traf6 f/f Cd4-Cre CD4 + T cells inhibited the accumulation of p52-RelB in the nucleus, thus blocking activation of the noncanonical NF-κB pathway (Fig. 7c,d) . TRAF6 therefore had a pivotal role in the induction of NIK after ligation of OX40 and in the subsequent activation of the noncanonical NF-κB pathway.
OX40 does not convert Traf6 f/f Cd4-Cre cells into T H 9 cells
To determine the role of TRAF6 in the induction of T H 9 cells, we sorted CD4 + T conv cells from wild-type B6 and Traf6 f/f Cd4-Cre mice by flow cytometry, stimulated them with anti-CD3 plus wild-type or OX40L-transgenic APCs under T H 9-polarizing conditions and assessed T H 9 induction at various time points. Wild-type B6 and Traf6 f/f Cd4-Cre CD4 + T cells had similar expression of OX40 after activation (Fig. 8a) ; they also demonstrated similar proliferation (CFSE dilution) 
npg
A r t i c l e s and survival (staining with annexin V) after stimulation with anti-CD3 plus APCs in vitro (Fig. 8b) . Ligation of OX40 converted a large fraction (~40%) of wild-type CD4 + T conv cells into T H 9 cells (Fig. 8c) .
In contrast, ligation of OX40 did not convert Traf6 f/f Cd4-Cre CD4 + T cells into T H 9 cells (<3%). This inhibition of T H 9 induction was very similar to that observed in p52-deficient cells (Fig. 6a) . The expression of PU.1, IRF4 and GATA-3 mRNA and protein was not very different in p52-deficient and Traf6 f/f Cd4-Cre CD4 + T cells and in wild-type B6 CD4 + T cells after activation (Supplementary Fig. 3 ).
To confirm that the lack of T H 9 induction of Traf6 f/f Cd4-Cre CD4 + T cells was truly due to impaired activation of p52-RelB, we transduced Traf6 f/f Cd4-Cre CD4 + T cells with retroviral vectors encoding RelB and p52; successfully transduced T cells were marked by GFP expression. We further cultured those GFP + Traf6 f/f Cd4-Cre CD4 + T cells for 3 d under T H 9-polarizing conditions (without ligation of OX40) and assessed the induction of IL-9-producing cells in the GFP + population by flow cytometry. Traf6 f/f Cd4-Cre T cells transduced with control vector did not produce detectable IL-9; however, Traf6 f/f Cd4-Cre T cells transduced to express p52-RelB readily became IL-9-producing cells under T H 9-polarizing conditions (Fig. 8d) . Conversely, CD4 + T cells transduced to express p50-RelA did not produce IL-9 under identical culture conditions (Fig. 8e) , which further demonstrated the importance of the p52-RelB pathway in the induction of T H 9 cells. Together these data identified an indispensable role for TRAF6 and p52-RelB in the OX40-mediated induction of T H 9 cells.
OX40 triggers T H 9 cell-mediated airway inflammation in vivo
To examine the role of the OX40-T H 9 axis in vivo, we first compared wildtype B6 and OX40L-transgenic mice for signs of tissue inflammation in vivo by histopathology. Consistent with a published report 16 , OX40L-transgenic mice developed signs of extensive autoimmune disease (data not shown). Histologically, the lungs were prominently involved, with signs of severe interstitial and airway inflammation 19 . Staining with Masson's trichrome showed epithelial hyperplasia and submucosal fibrosis, and staining with periodic acid-Schiff (PAS) andAlcian blue showed hyperproliferation of mucin-producing cells in the airway epithelium of OX40L-transgenic mice (Fig. 9a) . Quantitative assessment showed that as many as 30% of the airway epithelial cells were mucin-producing cells in OX40L-transgenic mice; this was reminiscent of results obtained with mice with transgenic overexpression of IL-9 in the lung airways 30 . Indeed, real-time PCR analysis of genes encoding a panel of proinflammatory cytokines showed high expression of the genes encoding IL-9 and IL-13 in the lung tissues of OX40L-transgenic mice but not in those of wild-type mice (Fig. 9b) . We further confirmed those results by flow cytometry, which identified an expanded population of CD4 + CD44 hi effectormemory T cells that spontaneously produced IL-9 in situ (Fig. 9c) .
In a different set of experiments, we injected the agonist mAb OX86 (anti-OX40) into wild-type and IL-9-deficient mice and then assessed changes in the lungs. Brief treatment with OX86 induced prominent bronchial epithelial hyperplasia and hyperproliferation of mucin-producing cells in the wild type mice, as shown by staining with PAS and Alcian blue (Fig. 9d) . In contrast, such changes were completely absent from similarly treated IL-9-deficient mice (Fig. 9d) . Furthermore, in a standard asthma model involving sensitization and rechallenge with OVA, hyperproliferation of mucin-producing cells was similarly induced in wild-type B6 mice but not in OX40-deficient mice (Fig. 9e) . ELISA showed that there was much less IL-9 in the npg bronchial alveolar lavage fluid from OVA-challenged OX40-deficient mice (0.08 ± 0.02 ng/ml; n = 3 mice) than in that from wild-type B6 mice (3.83 ± 0.43 ng/ml, n = 3 mice; P < 0.05 (unpaired two-tailed Student's t-test)). Additionally, T H 9 cells derived from OT-II cells under conditions of ligation of OX40 induced substantial proliferation of mucin-producing cells after adoptive transfer into mice deficient in recombination-activating gene 1, and this effect was inhibited considerably by neutralization of IL-9 ( Supplementary Fig. 4 ). Together these data demonstrated a direct role for OX40 in the induction of T H 9 cells and airway inflammation in vivo.
DISCUSSION IL-9-producing T H 9 cells are members of a subset of helper T cells 31, 32 .
However, the precise identity of T H 9 cells and the exact mechanisms that regulate their induction remain somewhat contested 18 . Here we have demonstrated several unique features of the induction of T H 9 cells. First, we found that the costimulatory molecule OX40 was unexpectedly potent in favoring the induction of T H 9 cells. Ligation of OX40, together with TGF-β and IL-4, converted as many as 80% of CD4 + T conv cells into T H 9 cells, which demonstrated the notable potency of this costimulatory pathway in the induction of T H 9 cells. Second, we identified a molecular mechanism by which OX40 favored T H 9 cells. Ligation of OX40 activated the ubiquitin ligase TRAF6, which mediated the activation of NIK; that resulted in the processing of p100 to generate the p52 subunit, which, together with RelB, formed the transcriptionally active p52-RelB complex. This noncanonical NF-κB pathway was essential for the induction of T H 9 cells by OX40. Third, the T H 9 cells induced by OX40 seemed to be distinct from other T H 9 cells reported in that they did not express other cytokines [31] [32] [33] , which suggested that the T H 9 cells generated under conditions of OX40 costimulation may have represented authentic T H 9 cells. This finding has further solidified T H 9 as a distinct subset of helper T cells and may facilitate further mechanistic studies of T H 9 cells as well as the role of T H 9 cells in various diseases. Finally, we have provided in vivo evidence that OX40 was critically important in driving the hyperproliferation of mucin-producing cells in the airway epithelium, which demonstrated the in vivo importance of T H 9 cells. In most studies, T H 9 cells are induced most effectively by TGF-β and IL-4 (ref. 34 ), but cells committed to IL-9 production are often in very low abundance (<10%), especially under conditions in which APCs are involved in the activation of CD4 + T cells 35 . This low frequency of T H 9 cells makes functional and mechanistic studies of such cells difficult and also casts considerable uncertainty on whether T H 9 cells are truly a separate lineage. In fact, T H 9 cells induced by TGF-β and IL-4 coexpress other cytokines, including IL-4 or IL-10 (refs. 31,32). The finding that T H 17 cells, T reg cells or even cells of the innate immune response can also express IL-9 suggests that IL-9 may be a cytokine shared among multiple cellular subsets 33, 36, 37 . This is a particular concern given that the transcription factors PU.1 and IRF4, although they are closely associated with T H 9 cells, are not specific to T H 9 cells and are also involved in the induction of other cell types, including T H 2 cells 38 . Here we have demonstrated that ligation of OX40, together with TGF-β and IL-4, induced a great abundance of T H 9 cells, and such T H 9 cells did not express the cytokines commonly expressed by T H 9 cells induced under other conditions 18 . Published studies have shown that OX40 potently shuts down the induction of IL-10 in activated T cells 39 . Those data, together with our finding that OX40 also turned off the induction of T H 17 cells and iT reg cells, suggest that T H 9 cells induced under conditions of stimulation via OX40 are different from those induced without ligation of OX40. Those induced by TGF-β and IL-4, possibly through the action of PU.1 and IRF4, may be metastable cells or intermediaries, as they have features of other helper T cell subsets, whereas additional OX40 signaling may promote further differentiation of T H 9 cells by turning off the expression of other cytokines. However, whether signaling via OX40 transiently modulates IL-9 expression while suppressing other cytokines or stably 'reprograms' the Il9 locus in differentiated T H 9 cells remains to be defined.
Despite its potency in inducing T H 9 cells, OX40 did not seem to operate through the well-described T H 9-associated transcription factors PU.1 and IRF4 (refs. 5,6) . Instead, ligation of OX40 triggered sustained activation of the noncanonical NF-κB pathway in CD4 + T cells that was critically involved in the induction of T H 9 cells. OX40 may be unique in this context, because we have found that stimulation via GITR, another member in the TNF receptor superfamily that is also expressed on activated CD4 + T cells 8 , failed to support T H 9 induction (X.X. et al., unpublished observations). Thus, there seems to be a certain degree of selectivity among members of the TNF receptor superfamily in activation of the noncanonical NF-κB pathway, but the exact mechanisms by which OX40 'preferentially' engages the p52-RelB pathway remain to be clearly defined. The promoter region of Il9 contains multiple NF-κB-binding sites, as does the conserved noncoding region of Il9 (ref. 18 ). Indeed, p52-RelB directly bound to the Il9 promoter region and triggered Il9 transcription under T H 9-polarizing conditions, but p50-RelA did not. Involvement of the noncanonical p52-RelB pathway does not exclude the importance of other factors in the induction of T H 9 cells. In fact, TGF-β and IL-4 are mandatory for optimal induction of T H 9 cells by OX40, as in the absence of TGF-β and IL-4, OX40 instead promotes a strong T H 1 response 9 . Thus, the noncanonical p52-RelB pathway probably acts together with other factors downstream of such cytokine signaling that collectively coordinate the induction of T H 9 cells, although the factors activated by the T H 9-polarizing cytokines are not known and were not addressed in our study here. Some emerging data suggest the possibility of the inhibition of T-bet by such cytokines 40 . Nonetheless, the notable effect of OX40 on the induction of T H 9 cells suggested that the p52-RelB pathway probably predominates this response, and other factors downstream of the polarizing cytokines may simply create a permissive environment for p52-RelB to act during T H 9 differentiation. In fact, two studies demonstrating the involvement of NF-κB in IL-9 expression in different settings and different cell types seem to support this idea 41, 42 . In addition, the effect of ligation of OX40 also involves the repression of T H 17 cells and iT reg cells, but the mechanisms responsible for such an effect await further identification. Studies in this area may provide additional insight into the role of OX40 in the control of T cell responses.
In summary, our study has identified OX40 as a powerful inducer of T H 9 cells and has identified a previously unknown mechanism triggered by OX40 in the selective induction of T H 9 cells. The T H 9 cells induced by OX40 were different from other reported T H 9 cells in that they had very high expression of IL-9 without expression of other T H 2 or T H 17 cytokines. Such T H 9 cells were stable, were induced in vivo and had a potent effect on airway epithelial cells and mucin-producing cells. Our findings may have important clinical implications 43 .
METHODS
Methods and any associated references are available in the online version of the paper.
